
|
The Canadian Thoracic Society released new guidelines on sleep disordered breathing, which provide the latest recommendations for sleep apnea diagnosis and treatment. The guidelines are created for health-care professionals by physicians who are experts in sleep disordered breathing. They are designed to keep health-care prof… |
|
Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) announced top-line results from an exploratory clinical study with its AMPAKINE® compound, CX1739 in subjects with sleep apnea. The study enrolled 20 relatively healthy adults with moderate-to-severe obstructive sleep apnea, 16 of which were administered a single oral dose of CX173… |
|
In a recent study that appeared in the Journal of Neuroscience, scientists demonstrated that repeated obstruction of the airways requires release of the brain chemical noradrenaline. The release of this chemical helps the brain learn to breathe more effectively and purposefully. “What we showed is that repeated disruption o… |
|
Cardiac Concepts Inc has conducted the first US clinical implant of the RespiCardia System at The Ohio State University Medical Center, Columbus. The RespiCardia System is a fully implantable device that is designed to restore more natural breathing patterns in patients with central sleep apnea. The procedure was performed by… |
|
DETROIT – Patients with obstructive sleep apnea who undergo surgery to improve their breathing get a better night’s sleep and therefore are less drowsy during the day, according to a new study from Henry Ford Hospital in Detroit. The study finds surgery greatly reduces daytime sleepiness – a common side effect from … |


